当前位置: X-MOL 学术Nat. Rev. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2022-02-18 , DOI: 10.1038/s41571-022-00611-7
Giulia Petroni 1 , Laura Santambrogio 1, 2, 3 , Silvia C. Formenti 1, 2, 4 , Lorenzo Galluzzi 1, 2, 3 , Lewis C. Cantley 2, 4
Affiliation  

Correction to: Nature Reviews Clinical Oncology https://doi.org/10.1038/s41571-021-00579w, published online 24 November 2021. The authors failed to explicitly recognize the major experimental and conceptual input of Dr. C. Norman Coleman and collaborators to the development of the therapeutic paradigm discussed in this review. The authors apologize to Dr. Coleman, his colleagues and the entire field of radiation oncology and have rectified the final section of the introduction to reflect this contribution. This omission has been corrected in both the HTML and PDF versions of this manuscript. https://doi.org/10.1038/s41571-022-00611-7 | Published online xx xx xxxx © Springer Nature Limited 2022 C o r r e C t i o n s

中文翻译:

作者更正:放射疗法作为一种在癌症中引发临床可操作信号通路的工具

更正为:Nature Reviews Clinical Oncology https://doi.org/10.1038/s41571-021-00579w,2021 年 11 月 24 日在线发布。作者未能明确认识到 C. Norman Coleman 博士及其合作者的主要实验和概念投入以发展本综述中讨论的治疗范式。作者向 Coleman 博士、他的同事和整个放射肿瘤学领域道歉,并更正了引言的最后部分以反映这一贡献。此遗漏已在本手稿的 HTML 和 PDF 版本中更正。https://doi.org/10.1038/s41571-022-00611-7 | 在线发表 xx xx xxxx © Springer Nature Limited 2022 C orre Ctions
更新日期:2022-02-18
down
wechat
bug